0001104659-11-055378.txt : 20111007 0001104659-11-055378.hdr.sgml : 20111007 20111007142607 ACCESSION NUMBER: 0001104659-11-055378 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111004 ITEM INFORMATION: Other Events FILED AS OF DATE: 20111007 DATE AS OF CHANGE: 20111007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MESA LABORATORIES INC /CO CENTRAL INDEX KEY: 0000724004 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 840872291 STATE OF INCORPORATION: CO FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-11740 FILM NUMBER: 111131941 BUSINESS ADDRESS: STREET 1: 12100 W 6TH AVE CITY: LAKEWOOD STATE: CO ZIP: 80228 BUSINESS PHONE: 3039878000 MAIL ADDRESS: STREET 1: 12100 W 6TH AVE CITY: LAKEWOOD STATE: CO ZIP: 80228 FORMER COMPANY: FORMER CONFORMED NAME: MESA MEDICAL INC DATE OF NAME CHANGE: 19921123 8-K 1 a11-27682_18k.htm 8-K

 

 

U.S. Securities and Exchange Commission

Washington, D.C. 20549

 

Form 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

OCTOBER 4,  2011

Date of Report (Date of earliest event Reported)

 

MESA LABORATORIES, INC.

(Exact Name of Small Business Issuer as Specified in its Charter)

 

Commission File Number: 0-11740

 

COLORADO

 

84-0872291

(State or other Jurisdiction of

 

(I.R.S. Employer

Incorporation or Organization)

 

Identification No.)

 

12100 WEST SIXTH AVENUE, LAKEWOOD,

 

 

COLORADO

 

80228

(Address of Principal Executive Offices)

 

(Zip Code)

 

Issuer’s telephone number, including area code: (303) 987-8000

 

Not Applicable.

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

ITEM 8.01   OTHER EVENTS.

 

Mesa Laboratories, Inc., on September 15, 2011, was contacted by the Staff at Nasdaq informing the Company that in its Definitive Proxy Statement filed August 11, 2011, Mr. Luke R. Schmieder, a non-independent director, served on the Nominating Committee.  Therefore, the Company was advised by Staff that it did not comply with Listing Rule 5605(e), which requires independent director oversite of director nominations.  On September 21, 2011 the Company notified the Staff that its Board of Directors had reconstituted the Committee, such that it now consists solely of independent directors.  The Staff has determined that the Company has regained compliance with Rule 5605(e), and the matter is now closed.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

MESA LABORATORIES,

                  INC.

               (Issuer)

 

 

DATED: October 7, 2011

BY:

/s/ John J. Sullivan

 

 

 

 

 

John J. Sullivan, Ph.D.

 

 

Chief Executive Officer, President, Treasurer and Director

 

2